e-learning
resources
London 2016
Sunday, 04.09.2016
Inflammatory biomarkers in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
TLR4 and NOD1 increase in stable COPD of increasing severity. Relationship with tissutal bacterial load
Antonino Di Stefano (Veruno, Italy), Antonino Di Stefano, Fabio L.M. Ricciardolo, Davide Vallese, Isabella Gnemmi, Valentina Sorbello, Paola Brun, Armando Capelli, Francesco Cappello, Bruno Balbi
Source:
International Congress 2016 – Inflammatory biomarkers in airway diseases
Session:
Inflammatory biomarkers in airway diseases
Session type:
Oral Presentation
Number:
487
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Antonino Di Stefano (Veruno, Italy), Antonino Di Stefano, Fabio L.M. Ricciardolo, Davide Vallese, Isabella Gnemmi, Valentina Sorbello, Paola Brun, Armando Capelli, Francesco Cappello, Bruno Balbi. TLR4 and NOD1 increase in stable COPD of increasing severity. Relationship with tissutal bacterial load. Eur Respir J 2016; 48: Suppl. 60, 487
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Association between qPCR bacterial load and airway inflammation in COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Presence of progranulin in airway inflammation associated with COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression
Source: Eur Respir J, 49 (5) 1602006; 10.1183/13993003.02006-2016
Year: 2017
Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients
Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Year: 2016
The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Different changes in plasma concentrations of cytokines and chemokines in patients with COPD associated with smoking and occupational exposures
Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes
Year: 2016
Increased serum level of apelin in chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
The influence of hyperinflation on body composition and cytokine profile in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Variation in the TLR4 gene and airway inflammation among patients with COPD
Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Year: 2009
IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
The relationship between systemic inflammation and vitamin D levels in COPD
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
Relationship of monocyte-derived macrophage phagocytosis to exacerbation susceptibility in stable COPD
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014
Micro-RNA-125a/b target A20 and MAVS to promote inflammatory and impair antiviral responses in chronic obstructive pulmonary disease
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Investigation the role of pentraxin-3 in the innate immune system in patients with COPD
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept